The Maharashtra Food and Drugs Administration (FDA) on Monday asked the public and licence holders to immediately stop the sale, distribution or use of Coldrif Syrup (Batch No. SR-13), following reports of child deaths in Madhya Pradesh and Rajasthan allegedly linked to the medicine.

The authority is currently coordinating with Tamil Nadu Drug Control Administration to trace the distribution of the syrup.

“The public is urged to remain cautious and to report any possession of Coldrif Syrup Batch No. SR-13 to the nearest Drugs Control Authority without delay,” the FDA said in a statement. The department warned that the batch, manufactured in May 2025 and expiring in April 2027, is suspected to be adulterated with Diethylene Glycol (DEG), a toxic chemical.

The statement said that th

See Full Page